Below are controversial cancer issues.
The Institute has examined the over-all available evidence and given its temporary position.
While there are many methodological problems with evidence collection, the ACR Institute feels that most FDA gun-raids against research labs and medical clinics that seek to find and offer innovative solutions to the challenge of reversing terminal cancer should not be authorized. If Congress allows this behavior, it may be that Congress’ laws are partially to blame for the USA’s cancer epidemics. See public policy section.
